Skip to main content
SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. logo

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603231 ISIN · CNE100006DV2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603231

About SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD.

https://www.solbar.com/

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. is a specialized manufacturer of high-quality soy protein ingredients. The company produces a comprehensive range of products, including soy protein isolates, functional concentrates, textured soy proteins, and soy fibers. These ingredients are utilized extensively in the global food and beverage sectors, serving applications in meat processing, plant-based alternatives, nutritional supplements, and bakery products. The company emphasizes the use of non-GMO raw materials and advanced processing technologies to ensure high functionality and nutritional value. Its operations focus on delivering consistent quality and technical support to meet the evolving demands of the health-conscious consumer market and industrial food production.

Recent filings

Filing Released Lang Actions
董事会二届九次会议独立董事意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from independent directors regarding the company's use of idle raised funds for cash management and deposit purposes. It references compliance with company law, company articles, and stock exchange regulations related to the use of raised funds. The content focuses on governance and regulatory compliance concerning fundraising usage, not on financial results, audit, or management changes. The document length is short (744 characters) and does not contain financial statements or detailed financial data. It is a regulatory compliance opinion related to fundraising usage, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like Capital/Financing Update (CAP) which would require announcements of financing activities rather than opinions on fund usage.
2023-12-29 Chinese
关于使用部分闲置募集资金进行现金管理及以协定存款方式存放募集资金余额的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Ningbo Suobao Protein Technology Co., Ltd. regarding the use of part of idle raised funds for cash management and depositing the remaining raised funds via agreed deposits. It details the board and supervisory meetings approving the use of idle raised funds, the investment scope, risk control measures, and compliance with regulatory requirements. The document references the approval of the initial public offering and the amount of raised funds but does not contain financial statements or detailed financial data. It is primarily a disclosure about the management and use of raised funds, including approvals and opinions from the board, supervisory committee, independent directors, and the sponsor. The document length is 4236 characters, relatively short, and it serves as a formal announcement of decisions and plans rather than a full financial report or audit. Therefore, it fits best into the category of Capital/Financing Update (CAP), as it updates on the company's fundraising proceeds usage and capital management activities.
2023-12-29 Chinese
索宝蛋白公司章程
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for 宁波索宝蛋白科技股份有限公司. It includes comprehensive sections on company general provisions, business scope, share issuance, shareholder rights, shareholder meetings, board of directors, senior management, supervisory board, financial accounting, profit distribution, auditing, notices and announcements, mergers, amendments to the charter, and other governance matters. The content is focused on the internal governance structure, shareholder meeting procedures, rights and obligations of shareholders, board and management roles, and related corporate governance rules. There is no indication that this is an annual report, earnings release, or any financial statement. Instead, it is a governance document outlining the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the full governance document, not just an announcement or summary.
2023-12-13 Chinese
索宝蛋白首次公开发行股票主板上市公告书提示性公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) and listing of Ningbo Suobao Protein Technology Co., Ltd. on the Shanghai Stock Exchange main board. It includes details about the stock code, number of shares issued, risk warnings related to stock price volatility, and contact information for the issuer and underwriters. The document does not contain financial statements or detailed financial performance data but serves as a formal notice of the company's stock listing and IPO details. The length is about 3,076 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Capital/Financing Update (CAP), as it relates to the company's fundraising activity and capital market listing.
2023-12-13 Chinese
索宝蛋白首次公开发行股票主板上市公告书
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票主板上市公告书" which translates to "Initial Public Offering (IPO) Main Board Listing Announcement." It contains detailed information about the company's stock listing on the Shanghai Stock Exchange, including stock code, listing date, shareholding structure, risk warnings, legal basis for the listing, shareholder information, and employee stock plans. The document is comprehensive and lengthy (15,000 characters), providing extensive details about the IPO and listing process. It is not a financial report like an annual or interim report, nor is it a simple announcement of a report. It is also not a transcript, audit report, or management change announcement. The content fits the category of a capital market announcement related to the company's financing and listing activities. Therefore, the most appropriate classification is "Capital/Financing Update (CAP)" as it updates on the company's fundraising and capital structure changes through the IPO and listing.
2023-12-13 Chinese
索宝蛋白首次公开发行股票并在主板上市招股说明书
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus (招股说明书) for an initial public offering (IPO) by 宁波索宝蛋白科技股份有限公司. It includes extensive information about the issuance of new shares, the number of shares, pricing, underwriting, financial data, risk factors, company background, governance, and use of proceeds. The document is not a typical annual report, earnings release, or management discussion but rather a comprehensive IPO prospectus. This type of document is best classified under Capital/Financing Update (CAP) because it relates to the company's fundraising activities and issuance of new shares to the public. The document length (15,000 characters) and detailed content confirm it is the full prospectus, not just an announcement or summary. Therefore, the appropriate classification is CAP with high confidence.
2023-12-07 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.